Results 121 to 130 of about 2,111,387 (147)
Specialty grand challenge: existing issues and emerging frontiers in renal endocrinology. [PDF]
Haque ATME, Razzaque MS.
europepmc +1 more source
The effect of tolvaptan on total kidney volume and inflammatory markers in autosomal dominant polycystic kidney disease. [PDF]
Oruc M +4 more
europepmc +1 more source
Diuretics in Cardiovascular Disease: For How Long and at What Dose? [PDF]
Paraskevaidis I, Tsougos E, Kourek C.
europepmc +1 more source
Functional Connections Between Insulin and Neurotrophin-3 in Hemodialysis Patients with Type 2 Diabetes. [PDF]
Gheorghiu M, Trandafir MF.
europepmc +1 more source
Successful treatment of chronic alcohol-induced refractory hyponatremia with tolvaptan: a case report with in-depth analysis of traditional treatment failure mechanisms. [PDF]
Yan K +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Australian Veterinary Journal, 2000
ObjectiveThe syndrome of inappropriate secretion of antidiuretic hormone is a rare disorder in dogs characterised by hypo‐osmolality and persistent arginine vasopressin production in the absence of hypovolaemia and/or hypotension. The study describes the efficacy and safety of the nonpeptide selective arginine vasopressin V2receptor antagonist OPC ...
Peter Irwin, L M Fleeman, Pa Phillips
exaly +6 more sources
ObjectiveThe syndrome of inappropriate secretion of antidiuretic hormone is a rare disorder in dogs characterised by hypo‐osmolality and persistent arginine vasopressin production in the absence of hypovolaemia and/or hypotension. The study describes the efficacy and safety of the nonpeptide selective arginine vasopressin V2receptor antagonist OPC ...
Peter Irwin, L M Fleeman, Pa Phillips
exaly +6 more sources
Translational Research, 2001
VPA-985 is an orally active, competitive vasopressin V(2) receptor antagonist that in normal human beings increases water excretion without affecting solute excretion. Whether solute excretion is affected in patients with hyponatremia resulting from inappropriate secretion of antidiuretic hormone (SIADH) or from cirrhosis treated with VPA-985 is ...
Guy Decaux
exaly +4 more sources
VPA-985 is an orally active, competitive vasopressin V(2) receptor antagonist that in normal human beings increases water excretion without affecting solute excretion. Whether solute excretion is affected in patients with hyponatremia resulting from inappropriate secretion of antidiuretic hormone (SIADH) or from cirrhosis treated with VPA-985 is ...
Guy Decaux
exaly +4 more sources
Molecular Cloning of the Receptor for Human Antidiuretic Hormone
Antidiuresis, the recovery of water from the lumen of the renal collecting tubule, is regulated by the hypothalamic release of antidiuretic hormone (ADH), which binds to specific receptors on renal collecting tubule cells, stimulates adenylyl cyclase and
Philippe Brabet +2 more
exaly +2 more sources

